Labyrinthitis: Difference between revisions

From OtoWiki
Jump to navigation Jump to search
VisualWikitext
(Created page with "{{infobox Disease |Title = |Aliases = |Image = |Caption = |ICD-9 = 386.30 |ICD-10 = H83. 09 |MeSH = |Gene = |Locus = |OMIM = |EyeWiki = |Radiopaedia = [https://radiopaedia.org/articles/labyrinthitis?lang=us Labyrinthitis] }} == Overview == [Needs added] === History === [Needs added] == Pathophysiology == === Relevant...")
 
No edit summary
 
Line 1: Line 1:
{{infobox Disease
{{infobox Disease
|Title              =  
|Title              = Labyrinthitis
|Aliases            =  
|Aliases            = Otitis interna, Inner ear infection
|Image              =  
|Image              =
|Caption            =  
|Caption            =
|ICD-9              = 386.30
|ICD-9              = 386.30
|ICD-10            = H83. 09
|ICD-10            = H83.0
|MeSH              =  
|MeSH              = D007762
|Gene              =  
|Gene              =
|Locus              =  
|Locus              =
|OMIM              =  
|OMIM              =
|EyeWiki            =  
|EyeWiki            =
|Radiopaedia        = [https://radiopaedia.org/articles/labyrinthitis?lang=us Labyrinthitis]
|Radiopaedia        = [https://radiopaedia.org/articles/labyrinthitis?lang=us Labyrinthitis]
}}
}}
== Overview ==
== Overview ==
[Needs added]
 
'''Labyrinthitis''' is an acute inflammatory condition affecting the membranous labyrinth, involving both the vestibular and cochlear portions of the inner ear.<ref name="Barkwill2025">Barkwill D, Winters R, Arora R. Labyrinthitis. In: StatPearls [Internet]. StatPearls Publishing; 2025 Jul 23. NCBI Bookshelf ID: NBK560506.</ref> The condition presents with acute vertigo, hearing loss, and tinnitus, distinguishing it from [[Vestibular Neuritis]], which affects only the vestibular nerve and spares hearing.<ref name="JHM2025">Johns Hopkins Medicine. Labyrinthitis and Vestibular Neuritis. https://www.hopkinsmedicine.org/health/conditions-and-diseases/labyrinthitis-and-vestibular-neuritis</ref>
 
Labyrinthitis may be caused by viral or bacterial infections, with viral labyrinthitis being more common.<ref name="Barkwill2025"/> Bacterial labyrinthitis is a serious condition that may arise from [[Acute Mastoiditis|otitis media]] or meningitis and can lead to permanent cochlear and vestibular damage if not promptly treated.<ref name="Emedicine2025">eMedicine Medscape. Labyrinthitis: Background, Etiology, Epidemiology. https://emedicine.medscape.com/article/856215-overview</ref> The distinction between viral and bacterial etiologies is critical for appropriate management, as is the distinction between serous (toxic) and suppurative labyrinthitis.
 
=== History ===
=== History ===
[Needs added]
 
The term "labyrinthitis" derives from the anatomical labyrinth of the inner ear. Historically, the condition was recognized as a complication of otitis media and meningitis, often with devastating consequences including deafness and death. The distinction between serous (toxic) and suppurative labyrinthitis was established in the pre-antibiotic era.
 
With the introduction of antibiotics in the mid-20th century, suppurative labyrinthitis became less common and less often fatal.<ref name="Barkwill2025"/> Viral labyrinthitis and vestibular neuritis emerged as more commonly recognized clinical entities. The development of audiometry and vestibular function testing allowed for more precise characterization of these conditions.


== Pathophysiology ==
== Pathophysiology ==
=== Relevant Anatomy ===
=== Relevant Anatomy ===
[Needs added]
 
'''Bony labyrinth''':
* '''Cochlea''': Spiral structure (2.5-2.75 turns) containing organ of Corti for hearing
* '''Vestibule''': Contains utricle and saccule (otolith organs) for linear acceleration and gravity detection
* '''Semicircular canals''': Three canals (superior, posterior, lateral) detecting angular acceleration
 
'''Membranous labyrinth''':
* Contained within bony labyrinth, filled with endolymph (high K+, low Na+)
* '''Cochlear duct (scala media)''': Contains hair cells for hearing
* '''Utricle and saccule''': Linear acceleration and gravity detection
* '''Semicircular canal ampullae''': Angular acceleration detection via crista ampullaris
 
'''Vestibular nerve''':
* Superior division: Innervates superior and lateral semicircular canals, utricle
* Inferior division: Innervates posterior semicircular canal, saccule
 
'''Cochlear nerve''':
* Innervates organ of Corti via spiral ganglion neurons
* Transmits auditory information to cochlear nuclei in brainstem
 
'''Blood supply''':
* '''Labyrinthine artery''' (branch of AICA, occasionally PICA): Sole blood supply to inner ear
* Vulnerable to ischemia; no collateral circulation
* Divides into anterior vestibular artery, vestibulocochlear artery, and cochlear artery
 
<gallery>
<gallery>
File:Gray920.png|Bony Labyrinth anatomy
File:Gray920.png|Bony Labyrinth anatomy
</gallery>
</gallery>
=== Disease Etiology ===
=== Disease Etiology ===
[Needs added]
 
'''Classification by etiology''':
 
==== Viral Labyrinthitis ====
 
Viral labyrinthitis is the most common form.<ref name="Barkwill2025"/>
 
'''Associated viruses''':<ref name="Radiopaedia2025">Radiopaedia.org. Labyrinthitis. https://radiopaedia.org/articles/labyrinthitis?lang=us</ref><ref name="VestDist2025">Vestibular Disorders Association. Labyrinthitis and Vestibular Neuritis. https://vestibular.org/article/diagnosis-treatment/types-of-vestibular-disorders/labyrinthitis-and-vestibular-neuritis/</ref>
* '''Herpes simplex virus (HSV-1)''': Most commonly implicated virus in vestibular neuritis
* '''Varicella-zoster virus (VZV)''': Causes Ramsay-Hunt syndrome (herpes zoster oticus) with facial palsy, otalgia, and vesicles
* '''Cytomegalovirus (CMV)''': Particularly in immunocompromised patients
* Epstein-Barr virus (EBV)
* Mumps, measles, rubella
* Influenza viruses
* Respiratory syncytial virus (RSV)
* Adenovirus
 
'''Pathophysiology''': Direct viral invasion of labyrinthine structures or immune-mediated inflammation following viral infection.<ref name="Barkwill2025"/> Often follows upper respiratory infection by 1-2 weeks.
 
==== Bacterial Labyrinthitis ====
 
'''Tympanogenic (from otitis media)''':<ref name="Radiopaedia2025"/>
* Extension from acute or chronic otitis media through round window membrane or oval window
* May occur via labyrinthine fistula (e.g., from cholesteatoma erosion)
* Pathogens: ''Streptococcus pneumoniae'', ''Haemophilus influenzae'', ''Staphylococcus aureus'', ''Pseudomonas aeruginosa''
 
'''Meningogenic (from meningitis)''':
* Bacteria enter via cochlear aqueduct or internal auditory canal
* Often bilateral involvement
* Pathogens: ''Neisseria meningitidis'', ''Streptococcus pneumoniae'', ''Haemophilus influenzae''
 
==== Serous vs. Suppurative Labyrinthitis ====
 
'''Serous (toxic) labyrinthitis''': Bacterial toxins and inflammatory mediators (cytokines, enzymes, complement) cross the round window membrane into the labyrinth without direct bacterial invasion; '''may be reversible''' if treated promptly with antibiotics and corticosteroids.<ref name="ScienceDirect2025">ScienceDirect. Labyrinthitis. https://www.sciencedirect.com/topics/immunology-and-microbiology/labyrinthitis</ref>
 
'''Suppurative labyrinthitis''': Direct bacterial invasion of the labyrinth with purulent infection; '''nearly always results in permanent and profound hearing loss'''.<ref name="ScienceDirect2025"/>
 
==== Other Causes ====
 
* Autoimmune inner ear disease (AIED)
* Trauma (temporal bone fracture, barotrauma)
* Ototoxicity (aminoglycosides, cisplatin)
* Post-surgical


== Diagnosis ==
== Diagnosis ==
=== Patient History ===
=== Patient History ===
[Needs added]
 
'''Acute presentation''' (distinguishes from Ménière's disease):
 
'''Vestibular symptoms''':
* '''Vertigo''': Sudden onset, severe, room-spinning sensation lasting days to weeks
* '''Nausea and vomiting''': Often prominent, especially early
* '''Gait instability''': Difficulty walking, falls toward affected side
* '''Duration''': Days to weeks (unlike BPPV which lasts seconds to minutes)
 
'''Auditory symptoms''' (KEY distinguishing feature from vestibular neuritis):<ref name="JHM2025"/>
* '''Hearing loss''': Typically unilateral sensorineural; may range from mild to profound
* '''Tinnitus''': Ipsilateral to affected ear, often prominent
* '''Aural fullness''': Sensation of ear blockage
 
'''Associated symptoms indicating specific etiology''':
* Recent upper respiratory infection (viral labyrinthitis)<ref name="Barkwill2025"/>
* Ear pain, otorrhea, fever (bacterial/otogenic)
* Headache, neck stiffness, photophobia (meningogenic)
* Facial weakness, vesicles on ear (Ramsay-Hunt syndrome)
 
=== Physical Examination ===
=== Physical Examination ===
[Needs added]
 
'''Vestibular examination''':
* '''Spontaneous nystagmus''': Horizontal or horizontal-torsional; fast phase beats away from affected side; suppressed by visual fixation (peripheral pattern)
* '''Head impulse test (HIT)''': Abnormal toward affected side with corrective catch-up saccade
* '''Romberg test''': Fall toward affected side
* '''Gait''': Deviation toward affected side
* '''Fukuda stepping test''': Rotation toward affected side
 
'''Otoscopy''':
* Normal (viral labyrinthitis)
* Acute otitis media, tympanic membrane perforation, cholesteatoma (bacterial)
* Vesicles on external ear/concha (Ramsay-Hunt syndrome)
* Mastoid tenderness (if mastoiditis)
 
'''Hearing assessment''':
* Rinne test: Air conduction > bone conduction bilaterally (sensorineural loss pattern)
* Weber test: Lateralizes to unaffected ear
 
'''Cranial nerve examination''':
* Facial nerve (VII): Assess for Ramsay-Hunt syndrome
* Other cranial nerves if meningitis suspected
 
=== Laboratory Tests ===
=== Laboratory Tests ===
[Needs added]
 
'''Routine labs''':
* CBC: Leukocytosis suggests bacterial infection
* Inflammatory markers (CRP, ESR)
 
'''Specific tests''':
* Blood cultures (if septic or bacterial etiology suspected)
* Lumbar puncture (if meningitis suspected)
* Viral serology (rarely changes acute management)
 
=== Imaging ===
=== Imaging ===
[Needs added]
 
==== MRI with Gadolinium ====
 
MRI is indicated when bacterial labyrinthitis, retrocochlear pathology, or atypical presentation is suspected.<ref name="Emedicine2025"/><ref name="ACR2024">Wang LL, Thompson TA, Shih RY, et al. ACR Appropriateness Criteria® Dizziness and Ataxia: 2023 Update. ''J Am Coll Radiol''. 2024;21(1):S18-S33. doi:10.1016/j.jacr.2023.10.002</ref>
 
'''Preferred sequence''': '''3D-FLAIR''' (pre- and post-contrast) is the optimal sequence for detecting labyrinthitis, identifying underlying labyrinthine conditions in 24-57% of patients with sudden sensorineural hearing loss.<ref name="Yoon2021">Yoon RG, Choi Y, Park HJ. Clinical usefulness of labyrinthine three-dimensional fluid-attenuated inversion recovery magnetic resonance images in idiopathic sudden sensorineural hearing loss. ''Curr Opin Otolaryngol Head Neck Surg''. 2021;29(5):367-373. doi:10.1097/MOO.0000000000000742</ref>
 
'''Characteristic MRI findings''':<ref name="Yoon2021"/><ref name="Kim2025">Kim KT, Park A, Lee SU, et al. Neurotologic findings of idiopathic acute unilateral audiovestibulopathy. ''Eur J Neurol''. 2025;32(1):e16489. doi:10.1111/ene.16489</ref><ref name="Hakim2022">Hakim A, Hool SL, Yassa N, et al. Signal alteration of the inner ear on high-resolution three-dimensional constructive interference in steady state sequence in patients with Ménière's disease and labyrinthitis. ''Audiol Neurootol''. 2022;27(4):299-307. doi:10.1159/000521592</ref>
* High signal intensity on 3D-FLAIR in vestibule (most common), cochlea, and/or semicircular canals
* Enhancement of labyrinthine structures on post-contrast T1-weighted images
* Enhancement of vestibular and/or cochlear nerves
* '''CISS hypointensity''' of inner ear structures (found in 40% of labyrinthitis cases versus 5% in Ménière's disease)<ref name="Hakim2022"/>
* Correlation between MRI findings and symptomatic side
 
'''Exclusion of other pathology''': Acoustic neuroma, cerebellopontine angle tumors, brainstem stroke, demyelinating disease.
 
==== High-Resolution CT Temporal Bone ====
 
Indicated when bacterial labyrinthitis is suspected:<ref name="Emedicine2025"/>
* Cholesteatoma with labyrinthine fistula
* Mastoiditis
* Bony erosion
* Labyrinthitis ossificans (late complication)
 
==== Audiometry ====
 
'''Essential test''' for confirming hearing loss and distinguishing labyrinthitis from vestibular neuritis.<ref name="JHM2025"/>
* Documents type and degree of sensorineural hearing loss (mild to profound)
* Important for baseline and follow-up monitoring
* Speech discrimination testing
 
==== Vestibular Function Testing ====
 
* '''Video head impulse test (vHIT)''': Quantifies VOR gain; abnormal toward affected side
* '''Videonystagmography (VNG)''': Documents nystagmus characteristics
* '''Caloric testing''': Shows reduced vestibular response (canal paresis) on affected side
* May be deferred in acute phase due to patient discomfort
 
'''Prognostic value of vHIT''': Posterior semicircular canal involvement (ipsilesional posterior canal gain <0.65) is associated with poorer hearing recovery.<ref name="Cho2022">Cho JW, Cho SI, Baek W, Kim MS, Nam GS. Significance of baseline inferior vestibular function on the prognosis of patients with labyrinthitis. ''Otol Neurotol''. 2022;43(9):e993-e999. doi:10.1097/MAO.0000000000003661</ref>
 
=== Differential Diagnosis ===
=== Differential Diagnosis ===
[Needs added]
 
* [[Vestibular Neuritis]] (no hearing loss)
* [[Meniere Disease|Ménière's disease]] (episodic, fluctuating hearing loss)
* Benign paroxysmal positional vertigo (brief episodes, positional triggers)
* Acoustic neuroma (gradual onset, asymmetric hearing loss)
* Brainstem stroke (central signs: direction-changing nystagmus, vertical nystagmus, normal HIT)
* Multiple sclerosis
* Perilymphatic fistula
* Superior semicircular canal dehiscence
* Otosyphilis
* Autoimmune inner ear disease


== Management ==
== Management ==
=== Medical Management ===
=== Medical Management ===
[Needs added]
 
==== Viral Labyrinthitis ====
 
'''Symptomatic treatment''' (short-term use only, 2-3 days):
* '''Vestibular suppressants''':
** Meclizine 25-50 mg PO q6-8h
** Dimenhydrinate 50 mg PO q6h
** Diazepam 2-5 mg PO q8h (for severe symptoms)
* '''Antiemetics''':
** Ondansetron 4-8 mg PO/IV q8h
** Promethazine 25 mg PO/PR q6h
 
'''Important''': Vestibular suppressants should be discontinued after 2-3 days as they impair central compensation.<ref name="JHM2025"/>
 
'''Corticosteroids''':
 
Corticosteroids improve '''vestibular function recovery''' but evidence for '''symptomatic benefit''' is limited, supporting '''shared decision-making''' rather than routine use.<ref name="GRACE2023">Edlow JA, Carpenter C, Akhter M, et al. Guidelines for Reasonable and Appropriate Care in the Emergency Department 3 (GRACE-3): Acute Dizziness and Vertigo in the Emergency Department. ''Acad Emerg Med''. 2023;30(5):442-486. doi:10.1111/acem.14728</ref>
 
'''Evidence for corticosteroids''':<ref name="Strupp2004">Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. ''N Engl J Med''. 2004;351(4):354-361. doi:10.1056/NEJMoa033280</ref><ref name="Bogdanova2022">Bogdanova A, Dlugaiczyk J, Heckmann JG, Schwab S. Corticosteroids in patients with vestibular neuritis: an updated meta-analysis. ''Acta Neurol Scand''. 2022;146(3):240-250. doi:10.1111/ane.13652</ref><ref name="Leong2021">Leong KJ, Lau T, Stewart V, Canetti EFD. Systematic review and meta-analysis: effectiveness of corticosteroids in treating adults with acute vestibular neuritis. ''Otolaryngol Head Neck Surg''. 2021;165(2):225-233. doi:10.1177/0194599820972919</ref>
* '''Physiologic benefit''': Methylprednisolone significantly improves peripheral vestibular function recovery (OR 3.1 for good acute outcomes; OR 2.4 for restoration of vestibular function at follow-up)<ref name="Bogdanova2022"/><ref name="Leong2021"/>
* The landmark Strupp NEJM trial showed mean improvement in vestibular paresis of 62.4% with methylprednisolone versus 39.6% with placebo at 12 months (P<0.001)<ref name="Strupp2004"/>
* '''Symptomatic benefit''': No clear benefit demonstrated for symptomatic recovery or quality of life<ref name="GRACE2023"/><ref name="Oliveira2023">Oliveira J E Silva L, Khoujah D, Naples JG, et al. Corticosteroids for patients with vestibular neuritis: an evidence synthesis for guidelines for reasonable and appropriate care in the emergency department. ''Acad Emerg Med''. 2023;30(5):524-534. doi:10.1111/acem.14699</ref>
* '''NNT/NNH''': Number needed to treat is 6-7; number needed to harm (adverse effects) is only 4<ref name="Bogdanova2022"/>
 
'''If corticosteroids are used''':
* Methylprednisolone 100 mg IV daily × 3 days, then oral taper over 3 weeks; OR
* Prednisone 1 mg/kg/day (max 60 mg) × 5-7 days, then taper
 
'''Antiviral therapy''':
 
'''Randomized controlled trials show no benefit from antiviral therapy in viral labyrinthitis/vestibular neuritis''', even when HSV-1 is the presumed etiology.<ref name="Strupp2004"/>
* The Strupp NEJM trial definitively demonstrated that valacyclovir does not improve outcomes (P=0.43)
* Mean improvement with valacyclovir alone (36.0%) was essentially identical to placebo (39.6%)
* Adding valacyclovir to methylprednisolone provides no additional benefit over steroids alone<ref name="Strupp2004"/>
 
'''Exception''': Ramsay-Hunt syndrome (VZV) may benefit from antivirals (valacyclovir 1000 mg PO TID × 7 days) combined with corticosteroids.<ref name="Barkwill2025"/>
 
==== Bacterial Labyrinthitis ====
 
'''Urgent treatment required''':<ref name="Emedicine2025"/>
 
'''Antibiotics''':
* IV broad-spectrum antibiotics with CNS penetration
* '''Empiric regimen''': Ceftriaxone 2g IV daily + Vancomycin 15-20 mg/kg IV q8-12h
* Duration: 2-4 weeks depending on source and response
* Adjusted based on culture and sensitivity results
 
'''Corticosteroids''':
* May help preserve hearing in bacterial labyrinthitis<ref name="Emedicine2025"/>
* Dexamethasone 0.15 mg/kg IV q6h often used as adjunct, especially in meningogenic cases
 
=== Surgical Management ===
=== Surgical Management ===
[Needs added]
 
'''Indications for surgery''' (bacterial labyrinthitis):
* Mastoiditis requiring mastoidectomy (see [[Acute Mastoiditis]], [[Bezold Abscess]])
* Cholesteatoma removal
* Labyrinthine fistula repair
* Meningitis source control
 
=== Vestibular Rehabilitation ===
 
'''Vestibular rehabilitation therapy (VRT)''' is an essential component of recovery and should be initiated within the '''first 2 weeks''' for optimal outcomes.<ref name="Kamo2023">Kamo T, Ogihara H, Azami M, Momosaki R, Fushiki H. Effects of early vestibular rehabilitation in patients with acute vestibular disorder: a systematic review and meta-analysis. ''Otol Neurotol''. 2023;44(4):e259-e266. doi:10.1097/MAO.0000000000003851</ref><ref name="Hall2022">Hall CD, Herdman SJ, Whitney SL, et al. Vestibular rehabilitation for peripheral vestibular hypofunction: an updated clinical practice guideline from the Academy of Neurologic Physical Therapy of the American Physical Therapy Association. ''J Neurol Phys Ther''. 2022;46(2):118-177. doi:10.1097/NPT.0000000000000382</ref>
 
'''Evidence for early VRT''':<ref name="Kamo2023"/><ref name="Tokle2019">Tokle G, Mørkved S, Bråthen G, et al. Efficacy of vestibular rehabilitation following acute vestibular neuritis: a randomized controlled trial. ''Otol Neurotol''. 2019;40(1):45-51. doi:10.1097/MAO.0000000000002088</ref><ref name="Kim2025b">Kim HS, Schauer JM, Kan AK, et al. Emergency department vestibular rehabilitation therapy for dizziness and vertigo: a nonrandomized clinical trial. ''JAMA Netw Open''. 2025;8(2):e2454123. doi:10.1001/jamanetworkopen.2024.54123</ref>
* Early vestibular rehabilitation (within 14 days) significantly improved Dizziness Handicap Inventory scores by -7.18 points (95% CI -10.48 to -3.88)<ref name="Kamo2023"/>
* VRT started early significantly reduced perceived dizziness at 3 months (p=0.007) and 12 months (p=0.001)<ref name="Tokle2019"/>
* Improved balance with eyes closed and reduced anxiety/depression measures<ref name="Tokle2019"/>
 
'''VRT components''':<ref name="Hall2022"/>
* '''Gaze stabilization exercises''': VOR adaptation and substitution
* '''Balance training''': Static and dynamic balance, proprioceptive exercises
* '''Habituation exercises''': Desensitization to provocative movements
* '''Walking and gait training'''
 
'''Program duration''': Supervised program typically 4-8 weeks; home exercises continued long-term.


== Outcomes ==
== Outcomes ==
=== Complications ===
=== Complications ===
[Needs added]
 
'''Vestibular''':
* Persistent vestibular hypofunction
* Chronic imbalance and oscillopsia
* Secondary benign paroxysmal positional vertigo
 
'''Auditory''':
* Permanent sensorineural hearing loss
* Chronic tinnitus
 
'''Bacterial labyrinthitis complications''':
* Meningitis
* Intracranial abscess (epidural, subdural, brain abscess)
* '''Labyrinthitis ossificans''': Fibrosis and ossification of labyrinth; may preclude cochlear implantation<ref name="Emedicine2025"/>
* Complete labyrinthine loss (dead ear)
 
=== Prognosis ===
=== Prognosis ===
[Needs added]
 
==== Viral Labyrinthitis ====
 
'''Vestibular recovery''': Generally favorable with 80-90% achieving functional recovery within 3-6 weeks through central vestibular compensation.<ref name="Cleveland2025">Cleveland Clinic. Labyrinthitis: What It Is & How To Treat It. https://my.clevelandclinic.edu/health/diseases/22032-labyrinthitis</ref><ref name="JHM2025"/>
 
'''Hearing recovery''': More variable than vestibular recovery.
* Only 20% achieve subjective hearing recovery in some studies<ref name="Cho2022"/>
* Other studies report 0-80% partial recovery<ref name="Cleveland2025"/>
* Hearing recovery is less predictable than vestibular recovery
 
'''Chronic symptoms''': Residual dizziness or imbalance persists in 10-20% of patients, requiring extended vestibular rehabilitation.<ref name="Cleveland2025"/>
 
'''Poor prognostic factors for hearing recovery''':<ref name="Cho2022"/>
* Abnormal inferior vestibular function (posterior canal involvement)
* Ipsilesional posterior canal gain <0.65 on video head impulse test (vHIT)
* Initial hearing loss >60 dB
* Older age
 
==== Bacterial Labyrinthitis ====
 
'''More guarded prognosis''':<ref name="Emedicine2025"/><ref name="ScienceDirect2025"/>
 
'''Serous (toxic) labyrinthitis''':
* '''Potentially reversible''' with early aggressive treatment (antibiotics + corticosteroids)
* Contemporary case reports demonstrate complete hearing recovery is possible when treated promptly
 
'''Suppurative labyrinthitis''':
* '''Nearly always results in profound permanent hearing loss'''<ref name="ScienceDirect2025"/>
* Early treatment with antibiotics significantly improves survival but rarely preserves hearing
* '''Labyrinthitis ossificans''' may develop within weeks to months, potentially precluding cochlear implantation<ref name="Emedicine2025"/>
 
'''Factors affecting recovery''':
* Age (younger patients compensate better due to superior neuroplasticity)
* Timing of vestibular rehabilitation (early initiation within 2 weeks accelerates recovery)<ref name="Kamo2023"/>
* Pre-existing vestibular dysfunction or hearing loss
* Completeness of labyrinthine destruction
* Compliance with rehabilitation therapy
* Underlying etiology (viral vs. bacterial; serous vs. suppurative)


== References ==
== References ==
<references />
<references />
[[Category:Otology]]
[[Category:Vestibular Disorders]]
[[Category:Infectious Disease]]

Latest revision as of 00:18, 3 February 2026


Overview

Labyrinthitis is an acute inflammatory condition affecting the membranous labyrinth, involving both the vestibular and cochlear portions of the inner ear.[1] The condition presents with acute vertigo, hearing loss, and tinnitus, distinguishing it from Vestibular Neuritis, which affects only the vestibular nerve and spares hearing.[2]

Labyrinthitis may be caused by viral or bacterial infections, with viral labyrinthitis being more common.[1] Bacterial labyrinthitis is a serious condition that may arise from otitis media or meningitis and can lead to permanent cochlear and vestibular damage if not promptly treated.[3] The distinction between viral and bacterial etiologies is critical for appropriate management, as is the distinction between serous (toxic) and suppurative labyrinthitis.

History

The term "labyrinthitis" derives from the anatomical labyrinth of the inner ear. Historically, the condition was recognized as a complication of otitis media and meningitis, often with devastating consequences including deafness and death. The distinction between serous (toxic) and suppurative labyrinthitis was established in the pre-antibiotic era.

With the introduction of antibiotics in the mid-20th century, suppurative labyrinthitis became less common and less often fatal.[1] Viral labyrinthitis and vestibular neuritis emerged as more commonly recognized clinical entities. The development of audiometry and vestibular function testing allowed for more precise characterization of these conditions.

Pathophysiology

Relevant Anatomy

Bony labyrinth:

  • Cochlea: Spiral structure (2.5-2.75 turns) containing organ of Corti for hearing
  • Vestibule: Contains utricle and saccule (otolith organs) for linear acceleration and gravity detection
  • Semicircular canals: Three canals (superior, posterior, lateral) detecting angular acceleration

Membranous labyrinth:

  • Contained within bony labyrinth, filled with endolymph (high K+, low Na+)
  • Cochlear duct (scala media): Contains hair cells for hearing
  • Utricle and saccule: Linear acceleration and gravity detection
  • Semicircular canal ampullae: Angular acceleration detection via crista ampullaris

Vestibular nerve:

  • Superior division: Innervates superior and lateral semicircular canals, utricle
  • Inferior division: Innervates posterior semicircular canal, saccule

Cochlear nerve:

  • Innervates organ of Corti via spiral ganglion neurons
  • Transmits auditory information to cochlear nuclei in brainstem

Blood supply:

  • Labyrinthine artery (branch of AICA, occasionally PICA): Sole blood supply to inner ear
  • Vulnerable to ischemia; no collateral circulation
  • Divides into anterior vestibular artery, vestibulocochlear artery, and cochlear artery
  • Bony Labyrinth anatomy

    Bony Labyrinth anatomy

Disease Etiology

Classification by etiology:

Viral Labyrinthitis

Viral labyrinthitis is the most common form.[1]

Associated viruses:[4][5]

  • Herpes simplex virus (HSV-1): Most commonly implicated virus in vestibular neuritis
  • Varicella-zoster virus (VZV): Causes Ramsay-Hunt syndrome (herpes zoster oticus) with facial palsy, otalgia, and vesicles
  • Cytomegalovirus (CMV): Particularly in immunocompromised patients
  • Epstein-Barr virus (EBV)
  • Mumps, measles, rubella
  • Influenza viruses
  • Respiratory syncytial virus (RSV)
  • Adenovirus

Pathophysiology: Direct viral invasion of labyrinthine structures or immune-mediated inflammation following viral infection.[1] Often follows upper respiratory infection by 1-2 weeks.

Bacterial Labyrinthitis

Tympanogenic (from otitis media):[4]

  • Extension from acute or chronic otitis media through round window membrane or oval window
  • May occur via labyrinthine fistula (e.g., from cholesteatoma erosion)
  • Pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Pseudomonas aeruginosa

Meningogenic (from meningitis):

  • Bacteria enter via cochlear aqueduct or internal auditory canal
  • Often bilateral involvement
  • Pathogens: Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae

Serous vs. Suppurative Labyrinthitis

Serous (toxic) labyrinthitis: Bacterial toxins and inflammatory mediators (cytokines, enzymes, complement) cross the round window membrane into the labyrinth without direct bacterial invasion; may be reversible if treated promptly with antibiotics and corticosteroids.[6]

Suppurative labyrinthitis: Direct bacterial invasion of the labyrinth with purulent infection; nearly always results in permanent and profound hearing loss.[6]

Other Causes

  • Autoimmune inner ear disease (AIED)
  • Trauma (temporal bone fracture, barotrauma)
  • Ototoxicity (aminoglycosides, cisplatin)
  • Post-surgical

Diagnosis

Patient History

Acute presentation (distinguishes from Ménière's disease):

Vestibular symptoms:

  • Vertigo: Sudden onset, severe, room-spinning sensation lasting days to weeks
  • Nausea and vomiting: Often prominent, especially early
  • Gait instability: Difficulty walking, falls toward affected side
  • Duration: Days to weeks (unlike BPPV which lasts seconds to minutes)

Auditory symptoms (KEY distinguishing feature from vestibular neuritis):[2]

  • Hearing loss: Typically unilateral sensorineural; may range from mild to profound
  • Tinnitus: Ipsilateral to affected ear, often prominent
  • Aural fullness: Sensation of ear blockage

Associated symptoms indicating specific etiology:

  • Recent upper respiratory infection (viral labyrinthitis)[1]
  • Ear pain, otorrhea, fever (bacterial/otogenic)
  • Headache, neck stiffness, photophobia (meningogenic)
  • Facial weakness, vesicles on ear (Ramsay-Hunt syndrome)

Physical Examination

Vestibular examination:

  • Spontaneous nystagmus: Horizontal or horizontal-torsional; fast phase beats away from affected side; suppressed by visual fixation (peripheral pattern)
  • Head impulse test (HIT): Abnormal toward affected side with corrective catch-up saccade
  • Romberg test: Fall toward affected side
  • Gait: Deviation toward affected side
  • Fukuda stepping test: Rotation toward affected side

Otoscopy:

  • Normal (viral labyrinthitis)
  • Acute otitis media, tympanic membrane perforation, cholesteatoma (bacterial)
  • Vesicles on external ear/concha (Ramsay-Hunt syndrome)
  • Mastoid tenderness (if mastoiditis)

Hearing assessment:

  • Rinne test: Air conduction > bone conduction bilaterally (sensorineural loss pattern)
  • Weber test: Lateralizes to unaffected ear

Cranial nerve examination:

  • Facial nerve (VII): Assess for Ramsay-Hunt syndrome
  • Other cranial nerves if meningitis suspected

Laboratory Tests

Routine labs:

  • CBC: Leukocytosis suggests bacterial infection
  • Inflammatory markers (CRP, ESR)

Specific tests:

  • Blood cultures (if septic or bacterial etiology suspected)
  • Lumbar puncture (if meningitis suspected)
  • Viral serology (rarely changes acute management)

Imaging

MRI with Gadolinium

MRI is indicated when bacterial labyrinthitis, retrocochlear pathology, or atypical presentation is suspected.[3][7]

Preferred sequence: 3D-FLAIR (pre- and post-contrast) is the optimal sequence for detecting labyrinthitis, identifying underlying labyrinthine conditions in 24-57% of patients with sudden sensorineural hearing loss.[8]

Characteristic MRI findings:[8][9][10]

  • High signal intensity on 3D-FLAIR in vestibule (most common), cochlea, and/or semicircular canals
  • Enhancement of labyrinthine structures on post-contrast T1-weighted images
  • Enhancement of vestibular and/or cochlear nerves
  • CISS hypointensity of inner ear structures (found in 40% of labyrinthitis cases versus 5% in Ménière's disease)[10]
  • Correlation between MRI findings and symptomatic side

Exclusion of other pathology: Acoustic neuroma, cerebellopontine angle tumors, brainstem stroke, demyelinating disease.

High-Resolution CT Temporal Bone

Indicated when bacterial labyrinthitis is suspected:[3]

  • Cholesteatoma with labyrinthine fistula
  • Mastoiditis
  • Bony erosion
  • Labyrinthitis ossificans (late complication)

Audiometry

Essential test for confirming hearing loss and distinguishing labyrinthitis from vestibular neuritis.[2]

  • Documents type and degree of sensorineural hearing loss (mild to profound)
  • Important for baseline and follow-up monitoring
  • Speech discrimination testing

Vestibular Function Testing

  • Video head impulse test (vHIT): Quantifies VOR gain; abnormal toward affected side
  • Videonystagmography (VNG): Documents nystagmus characteristics
  • Caloric testing: Shows reduced vestibular response (canal paresis) on affected side
  • May be deferred in acute phase due to patient discomfort

Prognostic value of vHIT: Posterior semicircular canal involvement (ipsilesional posterior canal gain <0.65) is associated with poorer hearing recovery.[11]

Differential Diagnosis

  • Vestibular Neuritis (no hearing loss)
  • Ménière's disease (episodic, fluctuating hearing loss)
  • Benign paroxysmal positional vertigo (brief episodes, positional triggers)
  • Acoustic neuroma (gradual onset, asymmetric hearing loss)
  • Brainstem stroke (central signs: direction-changing nystagmus, vertical nystagmus, normal HIT)
  • Multiple sclerosis
  • Perilymphatic fistula
  • Superior semicircular canal dehiscence
  • Otosyphilis
  • Autoimmune inner ear disease

Management

Medical Management

Viral Labyrinthitis

Symptomatic treatment (short-term use only, 2-3 days):

  • Vestibular suppressants:
    • Meclizine 25-50 mg PO q6-8h
    • Dimenhydrinate 50 mg PO q6h
    • Diazepam 2-5 mg PO q8h (for severe symptoms)
  • Antiemetics:
    • Ondansetron 4-8 mg PO/IV q8h
    • Promethazine 25 mg PO/PR q6h

Important: Vestibular suppressants should be discontinued after 2-3 days as they impair central compensation.[2]

Corticosteroids:

Corticosteroids improve vestibular function recovery but evidence for symptomatic benefit is limited, supporting shared decision-making rather than routine use.[12]

Evidence for corticosteroids:[13][14][15]

  • Physiologic benefit: Methylprednisolone significantly improves peripheral vestibular function recovery (OR 3.1 for good acute outcomes; OR 2.4 for restoration of vestibular function at follow-up)[14][15]
  • The landmark Strupp NEJM trial showed mean improvement in vestibular paresis of 62.4% with methylprednisolone versus 39.6% with placebo at 12 months (P<0.001)[13]
  • Symptomatic benefit: No clear benefit demonstrated for symptomatic recovery or quality of life[12][16]
  • NNT/NNH: Number needed to treat is 6-7; number needed to harm (adverse effects) is only 4[14]

If corticosteroids are used:

  • Methylprednisolone 100 mg IV daily × 3 days, then oral taper over 3 weeks; OR
  • Prednisone 1 mg/kg/day (max 60 mg) × 5-7 days, then taper

Antiviral therapy:

Randomized controlled trials show no benefit from antiviral therapy in viral labyrinthitis/vestibular neuritis, even when HSV-1 is the presumed etiology.[13]

  • The Strupp NEJM trial definitively demonstrated that valacyclovir does not improve outcomes (P=0.43)
  • Mean improvement with valacyclovir alone (36.0%) was essentially identical to placebo (39.6%)
  • Adding valacyclovir to methylprednisolone provides no additional benefit over steroids alone[13]

Exception: Ramsay-Hunt syndrome (VZV) may benefit from antivirals (valacyclovir 1000 mg PO TID × 7 days) combined with corticosteroids.[1]

Bacterial Labyrinthitis

Urgent treatment required:[3]

Antibiotics:

  • IV broad-spectrum antibiotics with CNS penetration
  • Empiric regimen: Ceftriaxone 2g IV daily + Vancomycin 15-20 mg/kg IV q8-12h
  • Duration: 2-4 weeks depending on source and response
  • Adjusted based on culture and sensitivity results

Corticosteroids:

  • May help preserve hearing in bacterial labyrinthitis[3]
  • Dexamethasone 0.15 mg/kg IV q6h often used as adjunct, especially in meningogenic cases

Surgical Management

Indications for surgery (bacterial labyrinthitis):

Vestibular Rehabilitation

Vestibular rehabilitation therapy (VRT) is an essential component of recovery and should be initiated within the first 2 weeks for optimal outcomes.[17][18]

Evidence for early VRT:[17][19][20]

  • Early vestibular rehabilitation (within 14 days) significantly improved Dizziness Handicap Inventory scores by -7.18 points (95% CI -10.48 to -3.88)[17]
  • VRT started early significantly reduced perceived dizziness at 3 months (p=0.007) and 12 months (p=0.001)[19]
  • Improved balance with eyes closed and reduced anxiety/depression measures[19]

VRT components:[18]

  • Gaze stabilization exercises: VOR adaptation and substitution
  • Balance training: Static and dynamic balance, proprioceptive exercises
  • Habituation exercises: Desensitization to provocative movements
  • Walking and gait training

Program duration: Supervised program typically 4-8 weeks; home exercises continued long-term.

Outcomes

Complications

Vestibular:

  • Persistent vestibular hypofunction
  • Chronic imbalance and oscillopsia
  • Secondary benign paroxysmal positional vertigo

Auditory:

  • Permanent sensorineural hearing loss
  • Chronic tinnitus

Bacterial labyrinthitis complications:

  • Meningitis
  • Intracranial abscess (epidural, subdural, brain abscess)
  • Labyrinthitis ossificans: Fibrosis and ossification of labyrinth; may preclude cochlear implantation[3]
  • Complete labyrinthine loss (dead ear)

Prognosis

Viral Labyrinthitis

Vestibular recovery: Generally favorable with 80-90% achieving functional recovery within 3-6 weeks through central vestibular compensation.[21][2]

Hearing recovery: More variable than vestibular recovery.

  • Only 20% achieve subjective hearing recovery in some studies[11]
  • Other studies report 0-80% partial recovery[21]
  • Hearing recovery is less predictable than vestibular recovery

Chronic symptoms: Residual dizziness or imbalance persists in 10-20% of patients, requiring extended vestibular rehabilitation.[21]

Poor prognostic factors for hearing recovery:[11]

  • Abnormal inferior vestibular function (posterior canal involvement)
  • Ipsilesional posterior canal gain <0.65 on video head impulse test (vHIT)
  • Initial hearing loss >60 dB
  • Older age

Bacterial Labyrinthitis

More guarded prognosis:[3][6]

Serous (toxic) labyrinthitis:

  • Potentially reversible with early aggressive treatment (antibiotics + corticosteroids)
  • Contemporary case reports demonstrate complete hearing recovery is possible when treated promptly

Suppurative labyrinthitis:

  • Nearly always results in profound permanent hearing loss[6]
  • Early treatment with antibiotics significantly improves survival but rarely preserves hearing
  • Labyrinthitis ossificans may develop within weeks to months, potentially precluding cochlear implantation[3]

Factors affecting recovery:

  • Age (younger patients compensate better due to superior neuroplasticity)
  • Timing of vestibular rehabilitation (early initiation within 2 weeks accelerates recovery)[17]
  • Pre-existing vestibular dysfunction or hearing loss
  • Completeness of labyrinthine destruction
  • Compliance with rehabilitation therapy
  • Underlying etiology (viral vs. bacterial; serous vs. suppurative)

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Barkwill D, Winters R, Arora R. Labyrinthitis. In: StatPearls [Internet]. StatPearls Publishing; 2025 Jul 23. NCBI Bookshelf ID: NBK560506.
  2. ↑ 2.0 2.1 2.2 2.3 2.4 Johns Hopkins Medicine. Labyrinthitis and Vestibular Neuritis. https://www.hopkinsmedicine.org/health/conditions-and-diseases/labyrinthitis-and-vestibular-neuritis
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 eMedicine Medscape. Labyrinthitis: Background, Etiology, Epidemiology. https://emedicine.medscape.com/article/856215-overview
  4. ↑ 4.0 4.1 Radiopaedia.org. Labyrinthitis. https://radiopaedia.org/articles/labyrinthitis?lang=us
  5. ↑ Vestibular Disorders Association. Labyrinthitis and Vestibular Neuritis. https://vestibular.org/article/diagnosis-treatment/types-of-vestibular-disorders/labyrinthitis-and-vestibular-neuritis/
  6. ↑ 6.0 6.1 6.2 6.3 ScienceDirect. Labyrinthitis. https://www.sciencedirect.com/topics/immunology-and-microbiology/labyrinthitis
  7. ↑ Wang LL, Thompson TA, Shih RY, et al. ACR Appropriateness Criteria® Dizziness and Ataxia: 2023 Update. J Am Coll Radiol. 2024;21(1):S18-S33. doi:10.1016/j.jacr.2023.10.002
  8. ↑ 8.0 8.1 Yoon RG, Choi Y, Park HJ. Clinical usefulness of labyrinthine three-dimensional fluid-attenuated inversion recovery magnetic resonance images in idiopathic sudden sensorineural hearing loss. Curr Opin Otolaryngol Head Neck Surg. 2021;29(5):367-373. doi:10.1097/MOO.0000000000000742
  9. ↑ Kim KT, Park A, Lee SU, et al. Neurotologic findings of idiopathic acute unilateral audiovestibulopathy. Eur J Neurol. 2025;32(1):e16489. doi:10.1111/ene.16489
  10. ↑ 10.0 10.1 Hakim A, Hool SL, Yassa N, et al. Signal alteration of the inner ear on high-resolution three-dimensional constructive interference in steady state sequence in patients with Ménière's disease and labyrinthitis. Audiol Neurootol. 2022;27(4):299-307. doi:10.1159/000521592
  11. ↑ 11.0 11.1 11.2 Cho JW, Cho SI, Baek W, Kim MS, Nam GS. Significance of baseline inferior vestibular function on the prognosis of patients with labyrinthitis. Otol Neurotol. 2022;43(9):e993-e999. doi:10.1097/MAO.0000000000003661
  12. ↑ 12.0 12.1 Edlow JA, Carpenter C, Akhter M, et al. Guidelines for Reasonable and Appropriate Care in the Emergency Department 3 (GRACE-3): Acute Dizziness and Vertigo in the Emergency Department. Acad Emerg Med. 2023;30(5):442-486. doi:10.1111/acem.14728
  13. ↑ 13.0 13.1 13.2 13.3 Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004;351(4):354-361. doi:10.1056/NEJMoa033280
  14. ↑ 14.0 14.1 14.2 Bogdanova A, Dlugaiczyk J, Heckmann JG, Schwab S. Corticosteroids in patients with vestibular neuritis: an updated meta-analysis. Acta Neurol Scand. 2022;146(3):240-250. doi:10.1111/ane.13652
  15. ↑ 15.0 15.1 Leong KJ, Lau T, Stewart V, Canetti EFD. Systematic review and meta-analysis: effectiveness of corticosteroids in treating adults with acute vestibular neuritis. Otolaryngol Head Neck Surg. 2021;165(2):225-233. doi:10.1177/0194599820972919
  16. ↑ Oliveira J E Silva L, Khoujah D, Naples JG, et al. Corticosteroids for patients with vestibular neuritis: an evidence synthesis for guidelines for reasonable and appropriate care in the emergency department. Acad Emerg Med. 2023;30(5):524-534. doi:10.1111/acem.14699
  17. ↑ 17.0 17.1 17.2 17.3 Kamo T, Ogihara H, Azami M, Momosaki R, Fushiki H. Effects of early vestibular rehabilitation in patients with acute vestibular disorder: a systematic review and meta-analysis. Otol Neurotol. 2023;44(4):e259-e266. doi:10.1097/MAO.0000000000003851
  18. ↑ 18.0 18.1 Hall CD, Herdman SJ, Whitney SL, et al. Vestibular rehabilitation for peripheral vestibular hypofunction: an updated clinical practice guideline from the Academy of Neurologic Physical Therapy of the American Physical Therapy Association. J Neurol Phys Ther. 2022;46(2):118-177. doi:10.1097/NPT.0000000000000382
  19. ↑ 19.0 19.1 19.2 Tokle G, Mørkved S, Bråthen G, et al. Efficacy of vestibular rehabilitation following acute vestibular neuritis: a randomized controlled trial. Otol Neurotol. 2019;40(1):45-51. doi:10.1097/MAO.0000000000002088
  20. ↑ Kim HS, Schauer JM, Kan AK, et al. Emergency department vestibular rehabilitation therapy for dizziness and vertigo: a nonrandomized clinical trial. JAMA Netw Open. 2025;8(2):e2454123. doi:10.1001/jamanetworkopen.2024.54123
  21. ↑ 21.0 21.1 21.2 Cleveland Clinic. Labyrinthitis: What It Is & How To Treat It. https://my.clevelandclinic.edu/health/diseases/22032-labyrinthitis
Retrieved from "http://otowiki.org/index.php?title=Labyrinthitis&oldid=339"